Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Chilcott

Showing results (21-30 of 48) with videos related to

Pageof 5
Sort By:
The European Respiratory Journal|March 29, 2003
The cost-effectiveness of nCPAP treatment in patients with moderate-to-severe obstructive sleep apnoeaJ Mar, J R Rueda, J Durán-Cantolla, et al.
Health Technology Assessment (Winchester, England)|November 16, 2002
A systematic review and economic evaluation of computerised cognitive behaviour therapy for depression and anxietyE Kaltenthaler, P Shackley, K Stevens, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
Layering Interventions for Type-2 Diabetes Prevention Using The Sphr Diabetes ModelC Thomas, P Watson, C Greaves, et al.
Health Technology Assessment (Winchester, England)|April 1, 2009
Spinal cord stimulation for chronic pain of neuropathic or ischaemic origin: systematic review and economic evaluationE L Simpson, A Duenas, M W Holmes, et al.
Clinical Chemistry|March 1, 1985
EktaChem assay for phosphorus evaluatedV Warty, J Chilcott, V Soncini, et al.
Transfusion Medicine (Oxford, England)|June 16, 2012
National audit of the use of fibrinogen concentrate to correct hypofibrinogenaemiaN D Gollop, J Chilcott, A Benton, et al.
Health Technology Assessment (Winchester, England)|March 25, 2004
Clinical effectiveness and cost-effectiveness of pioglitazone and rosiglitazone in the treatment of type 2 diabetes: a systematic review and economic evaluationC Czoski-Murray, E Warren, J Chilcott, et al.
Health Technology Assessment (Winchester, England)|March 14, 2003
A review of the clinical effectiveness and cost-effectiveness of routine anti-D prophylaxis for pregnant women who are rhesus-negativeJ Chilcott, M Lloyd Jones, J Wight, et al.
Health Technology Assessment (Winchester, England)|May 27, 2010
Avoiding and identifying errors in health technology assessment models: qualitative study and methodological reviewJ Chilcott, P Tappenden, A Rawdin, et al.
Health Technology Assessment (Winchester, England)|May 20, 2008
Ezetimibe for the treatment of hypercholesterolaemia: a systematic review and economic evaluationR Ara, I Tumur, A Pandor, et al.
Pageof 5

Showing results (21-30 of 48) with videos related to

Sort By:
Pageof 5
The European Respiratory Journal|March 29, 2003
The cost-effectiveness of nCPAP treatment in patients with moderate-to-severe obstructive sleep apnoeaJ Mar, J R Rueda, J Durán-Cantolla, et al.
Health Technology Assessment (Winchester, England)|November 16, 2002
A systematic review and economic evaluation of computerised cognitive behaviour therapy for depression and anxietyE Kaltenthaler, P Shackley, K Stevens, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
Layering Interventions for Type-2 Diabetes Prevention Using The Sphr Diabetes ModelC Thomas, P Watson, C Greaves, et al.
Health Technology Assessment (Winchester, England)|April 1, 2009
Spinal cord stimulation for chronic pain of neuropathic or ischaemic origin: systematic review and economic evaluationE L Simpson, A Duenas, M W Holmes, et al.
Clinical Chemistry|March 1, 1985
EktaChem assay for phosphorus evaluatedV Warty, J Chilcott, V Soncini, et al.
Transfusion Medicine (Oxford, England)|June 16, 2012
National audit of the use of fibrinogen concentrate to correct hypofibrinogenaemiaN D Gollop, J Chilcott, A Benton, et al.
Health Technology Assessment (Winchester, England)|March 25, 2004
Clinical effectiveness and cost-effectiveness of pioglitazone and rosiglitazone in the treatment of type 2 diabetes: a systematic review and economic evaluationC Czoski-Murray, E Warren, J Chilcott, et al.
Health Technology Assessment (Winchester, England)|March 14, 2003
A review of the clinical effectiveness and cost-effectiveness of routine anti-D prophylaxis for pregnant women who are rhesus-negativeJ Chilcott, M Lloyd Jones, J Wight, et al.
Health Technology Assessment (Winchester, England)|May 27, 2010
Avoiding and identifying errors in health technology assessment models: qualitative study and methodological reviewJ Chilcott, P Tappenden, A Rawdin, et al.
Health Technology Assessment (Winchester, England)|May 20, 2008
Ezetimibe for the treatment of hypercholesterolaemia: a systematic review and economic evaluationR Ara, I Tumur, A Pandor, et al.
Pageof 5